Cohance Lifesciences Closes Trading Window for Insider Trading

Cohance Lifesciences Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from October 1, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter and half-year ending September 30, 2026. The exact date of the board meeting to approve these results will be communicated later. This measure is standard practice to prevent potential insider trading before the public release of financial information.